3-D Matrix, Ltd.
3-D Matrix, Ltd. (DMTRF) Stock Competitors & Peer Comparison
See (DMTRF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DMTRF | $2.25 | +0.00% | 270.5M | -112.50 | -$0.02 | N/A |
| SEMHF | $40.65 | +1.09% | 45.5B | 18.48 | $2.20 | +2.96% |
| RSMDF | $29.82 | +66.31% | 43.3B | 28.67 | $1.04 | +1.25% |
| FUJIY | $10.53 | +1.64% | 25.4B | 15.04 | $0.70 | +1.87% |
| RYLPF | $25.44 | -4.83% | 24.2B | 21.93 | $1.16 | +3.72% |
| FUJIF | $20.00 | +0.00% | 23.9B | 14.18 | $1.41 | +2.28% |
| SMMNY | $19.95 | -1.77% | 22.3B | 18.15 | $1.10 | +2.92% |
| SONVF | $268.00 | +0.00% | 15.9B | 23.43 | $11.44 | +1.97% |
| SONVY | $52.04 | -1.53% | 15.5B | 22.79 | $2.29 | +2.03% |
| CLPBY | $6.01 | -3.06% | 13.5B | 40.07 | $0.15 | +5.80% |
Stock Comparison
DMTRF vs SEMHF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, SEMHF has a market cap of 45.5B. Regarding current trading prices, DMTRF is priced at $2.25, while SEMHF trades at $40.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas SEMHF's P/E ratio is 18.48. In terms of profitability, DMTRF's ROE is +0.36%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, DMTRF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SEMHF's competition here
DMTRF vs RSMDF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, RSMDF has a market cap of 43.3B. Regarding current trading prices, DMTRF is priced at $2.25, while RSMDF trades at $29.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas RSMDF's P/E ratio is 28.67. In terms of profitability, DMTRF's ROE is +0.36%, compared to RSMDF's ROE of +0.24%. Regarding short-term risk, DMTRF is more volatile compared to RSMDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check RSMDF's competition here
DMTRF vs FUJIY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, FUJIY has a market cap of 25.4B. Regarding current trading prices, DMTRF is priced at $2.25, while FUJIY trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas FUJIY's P/E ratio is 15.04. In terms of profitability, DMTRF's ROE is +0.36%, compared to FUJIY's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to FUJIY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check FUJIY's competition here
DMTRF vs RYLPF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, RYLPF has a market cap of 24.2B. Regarding current trading prices, DMTRF is priced at $2.25, while RYLPF trades at $25.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas RYLPF's P/E ratio is 21.93. In terms of profitability, DMTRF's ROE is +0.36%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, DMTRF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check RYLPF's competition here
DMTRF vs FUJIF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, FUJIF has a market cap of 23.9B. Regarding current trading prices, DMTRF is priced at $2.25, while FUJIF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas FUJIF's P/E ratio is 14.18. In terms of profitability, DMTRF's ROE is +0.36%, compared to FUJIF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to FUJIF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check FUJIF's competition here
DMTRF vs SMMNY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, SMMNY has a market cap of 22.3B. Regarding current trading prices, DMTRF is priced at $2.25, while SMMNY trades at $19.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas SMMNY's P/E ratio is 18.15. In terms of profitability, DMTRF's ROE is +0.36%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, DMTRF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SMMNY's competition here
DMTRF vs SONVF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, SONVF has a market cap of 15.9B. Regarding current trading prices, DMTRF is priced at $2.25, while SONVF trades at $268.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas SONVF's P/E ratio is 23.43. In terms of profitability, DMTRF's ROE is +0.36%, compared to SONVF's ROE of +0.21%. Regarding short-term risk, DMTRF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SONVF's competition here
DMTRF vs SONVY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, SONVY has a market cap of 15.5B. Regarding current trading prices, DMTRF is priced at $2.25, while SONVY trades at $52.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas SONVY's P/E ratio is 22.79. In terms of profitability, DMTRF's ROE is +0.36%, compared to SONVY's ROE of +0.22%. Regarding short-term risk, DMTRF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SONVY's competition here
DMTRF vs CLPBY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CLPBY has a market cap of 13.5B. Regarding current trading prices, DMTRF is priced at $2.25, while CLPBY trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CLPBY's P/E ratio is 40.07. In terms of profitability, DMTRF's ROE is +0.36%, compared to CLPBY's ROE of +0.14%. Regarding short-term risk, DMTRF is more volatile compared to CLPBY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CLPBY's competition here
DMTRF vs CLPBF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CLPBF has a market cap of 13.5B. Regarding current trading prices, DMTRF is priced at $2.25, while CLPBF trades at $65.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CLPBF's P/E ratio is 44.94. In terms of profitability, DMTRF's ROE is +0.36%, compared to CLPBF's ROE of +0.14%. Regarding short-term risk, DMTRF is more volatile compared to CLPBF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CLPBF's competition here
DMTRF vs SNNUF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, SNNUF has a market cap of 12.7B. Regarding current trading prices, DMTRF is priced at $2.25, while SNNUF trades at $14.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas SNNUF's P/E ratio is 20.76. In terms of profitability, DMTRF's ROE is +0.36%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, DMTRF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SNNUF's competition here
DMTRF vs OCPNF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, OCPNF has a market cap of 12.3B. Regarding current trading prices, DMTRF is priced at $2.25, while OCPNF trades at $11.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas OCPNF's P/E ratio is 29.42. In terms of profitability, DMTRF's ROE is +0.36%, compared to OCPNF's ROE of +0.09%. Regarding short-term risk, DMTRF is more volatile compared to OCPNF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check OCPNF's competition here
DMTRF vs WILYY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, WILYY has a market cap of 8.3B. Regarding current trading prices, DMTRF is priced at $2.25, while WILYY trades at $19.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas WILYY's P/E ratio is 22.59. In terms of profitability, DMTRF's ROE is +0.36%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, DMTRF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check WILYY's competition here
DMTRF vs WILLF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, WILLF has a market cap of 7.5B. Regarding current trading prices, DMTRF is priced at $2.25, while WILLF trades at $35.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas WILLF's P/E ratio is 20.37. In terms of profitability, DMTRF's ROE is +0.36%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, DMTRF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check WILLF's competition here
DMTRF vs GNGBY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, GNGBY has a market cap of 5.4B. Regarding current trading prices, DMTRF is priced at $2.25, while GNGBY trades at $19.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas GNGBY's P/E ratio is 21.33. In terms of profitability, DMTRF's ROE is +0.36%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check GNGBY's competition here
DMTRF vs GNGBF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, DMTRF is priced at $2.25, while GNGBF trades at $20.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas GNGBF's P/E ratio is 21.56. In terms of profitability, DMTRF's ROE is +0.36%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check GNGBF's competition here
DMTRF vs YPHDF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, YPHDF has a market cap of 4.8B. Regarding current trading prices, DMTRF is priced at $2.25, while YPHDF trades at $367.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas YPHDF's P/E ratio is 17.78. In terms of profitability, DMTRF's ROE is +0.36%, compared to YPHDF's ROE of +0.38%. Regarding short-term risk, DMTRF is more volatile compared to YPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check YPHDF's competition here
DMTRF vs CHEOF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CHEOF has a market cap of 4.7B. Regarding current trading prices, DMTRF is priced at $2.25, while CHEOF trades at $72.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CHEOF's P/E ratio is 19.29. In terms of profitability, DMTRF's ROE is +0.36%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, DMTRF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CHEOF's competition here
DMTRF vs CHEOY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CHEOY has a market cap of 4.7B. Regarding current trading prices, DMTRF is priced at $2.25, while CHEOY trades at $36.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CHEOY's P/E ratio is 19.26. In terms of profitability, DMTRF's ROE is +0.36%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, DMTRF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CHEOY's competition here
DMTRF vs NHNKY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, NHNKY has a market cap of 2.8B. Regarding current trading prices, DMTRF is priced at $2.25, while NHNKY trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas NHNKY's P/E ratio is 15.71. In terms of profitability, DMTRF's ROE is +0.36%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check NHNKY's competition here
DMTRF vs AMFPF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, AMFPF has a market cap of 2.6B. Regarding current trading prices, DMTRF is priced at $2.25, while AMFPF trades at $12.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas AMFPF's P/E ratio is 33.36. In terms of profitability, DMTRF's ROE is +0.36%, compared to AMFPF's ROE of +0.07%. Regarding short-term risk, DMTRF is more volatile compared to AMFPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AMFPF's competition here
DMTRF vs AMBBY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, AMBBY has a market cap of 2.6B. Regarding current trading prices, DMTRF is priced at $2.25, while AMBBY trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas AMBBY's P/E ratio is 35.64. In terms of profitability, DMTRF's ROE is +0.36%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AMBBY's competition here
DMTRF vs AMBFF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, AMBFF has a market cap of 2.6B. Regarding current trading prices, DMTRF is priced at $2.25, while AMBFF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas AMBFF's P/E ratio is 35.36. In terms of profitability, DMTRF's ROE is +0.36%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AMBFF's competition here
DMTRF vs GNNDY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, DMTRF is priced at $2.25, while GNNDY trades at $45.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas GNNDY's P/E ratio is 53.85. In terms of profitability, DMTRF's ROE is +0.36%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, DMTRF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check GNNDY's competition here
DMTRF vs OSSFF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, DMTRF is priced at $2.25, while OSSFF trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas OSSFF's P/E ratio is 25.55. In terms of profitability, DMTRF's ROE is +0.36%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check OSSFF's competition here
DMTRF vs DRWKF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, DMTRF is priced at $2.25, while DRWKF trades at $111.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas DRWKF's P/E ratio is 11.79. In terms of profitability, DMTRF's ROE is +0.36%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check DRWKF's competition here
DMTRF vs GGNDF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, DMTRF is priced at $2.25, while GGNDF trades at $14.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas GGNDF's P/E ratio is 51.25. In terms of profitability, DMTRF's ROE is +0.36%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, DMTRF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check GGNDF's competition here
DMTRF vs MCRPF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, MCRPF has a market cap of 1.9B. Regarding current trading prices, DMTRF is priced at $2.25, while MCRPF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas MCRPF's P/E ratio is -10.77. In terms of profitability, DMTRF's ROE is +0.36%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, DMTRF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check MCRPF's competition here
DMTRF vs OSSUY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, OSSUY has a market cap of 1.8B. Regarding current trading prices, DMTRF is priced at $2.25, while OSSUY trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas OSSUY's P/E ratio is 20.65. In terms of profitability, DMTRF's ROE is +0.36%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check OSSUY's competition here
DMTRF vs DWRKF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, DMTRF is priced at $2.25, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, DMTRF's ROE is +0.36%, compared to DWRKF's ROE of N/A. Regarding short-term risk, DMTRF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check DWRKF's competition here
DMTRF vs NHNKF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, NHNKF has a market cap of 1.7B. Regarding current trading prices, DMTRF is priced at $2.25, while NHNKF trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas NHNKF's P/E ratio is 30.28. In terms of profitability, DMTRF's ROE is +0.36%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check NHNKF's competition here
DMTRF vs MEDGF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, DMTRF is priced at $2.25, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, DMTRF's ROE is +0.36%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, DMTRF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check MEDGF's competition here
DMTRF vs BOEUF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, BOEUF has a market cap of 1.6B. Regarding current trading prices, DMTRF is priced at $2.25, while BOEUF trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas BOEUF's P/E ratio is 83.30. In terms of profitability, DMTRF's ROE is +0.36%, compared to BOEUF's ROE of +0.22%. Regarding short-term risk, DMTRF is more volatile compared to BOEUF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check BOEUF's competition here
DMTRF vs VTRLY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, DMTRF is priced at $2.25, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas VTRLY's P/E ratio is -2.76. In terms of profitability, DMTRF's ROE is +0.36%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, DMTRF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check VTRLY's competition here
DMTRF vs FDMDF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, FDMDF has a market cap of 1.5B. Regarding current trading prices, DMTRF is priced at $2.25, while FDMDF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas FDMDF's P/E ratio is -8.62. In terms of profitability, DMTRF's ROE is +0.36%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, DMTRF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check FDMDF's competition here
DMTRF vs MDRSF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, DMTRF is priced at $2.25, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas MDRSF's P/E ratio is 135.29. In terms of profitability, DMTRF's ROE is +0.36%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, DMTRF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check MDRSF's competition here
DMTRF vs DGWPF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, DGWPF has a market cap of 1.4B. Regarding current trading prices, DMTRF is priced at $2.25, while DGWPF trades at $72.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas DGWPF's P/E ratio is 7.62. In terms of profitability, DMTRF's ROE is +0.36%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check DGWPF's competition here
DMTRF vs LFTSF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, DMTRF is priced at $2.25, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, DMTRF's ROE is +0.36%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, DMTRF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check LFTSF's competition here
DMTRF vs ELEAF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, ELEAF has a market cap of 759.8M. Regarding current trading prices, DMTRF is priced at $2.25, while ELEAF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas ELEAF's P/E ratio is 12.31. In terms of profitability, DMTRF's ROE is +0.36%, compared to ELEAF's ROE of +0.17%. Regarding short-term risk, DMTRF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ELEAF's competition here
DMTRF vs XVIPF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, XVIPF has a market cap of 603.2M. Regarding current trading prices, DMTRF is priced at $2.25, while XVIPF trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas XVIPF's P/E ratio is 76.60. In terms of profitability, DMTRF's ROE is +0.36%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, DMTRF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check XVIPF's competition here
DMTRF vs BRSYF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, BRSYF has a market cap of 543.2M. Regarding current trading prices, DMTRF is priced at $2.25, while BRSYF trades at $13.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas BRSYF's P/E ratio is 61.59. In terms of profitability, DMTRF's ROE is +0.36%, compared to BRSYF's ROE of +0.12%. Regarding short-term risk, DMTRF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check BRSYF's competition here
DMTRF vs IOBCF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, IOBCF has a market cap of 501.5M. Regarding current trading prices, DMTRF is priced at $2.25, while IOBCF trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas IOBCF's P/E ratio is 34.90. In terms of profitability, DMTRF's ROE is +0.36%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check IOBCF's competition here
DMTRF vs AVMR Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, DMTRF is priced at $2.25, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas AVMR's P/E ratio is -18.34. In terms of profitability, DMTRF's ROE is +0.36%, compared to AVMR's ROE of -0.23%. Regarding short-term risk, DMTRF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AVMR's competition here
DMTRF vs CALZF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CALZF has a market cap of 414.5M. Regarding current trading prices, DMTRF is priced at $2.25, while CALZF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CALZF's P/E ratio is 60.00. In terms of profitability, DMTRF's ROE is +0.36%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, DMTRF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CALZF's competition here
DMTRF vs HYBT Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, DMTRF is priced at $2.25, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas HYBT's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is +0.36%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, DMTRF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check HYBT's competition here
DMTRF vs CYBQY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CYBQY has a market cap of 333.5M. Regarding current trading prices, DMTRF is priced at $2.25, while CYBQY trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CYBQY's P/E ratio is -187.00. In terms of profitability, DMTRF's ROE is +0.36%, compared to CYBQY's ROE of +0.01%. Regarding short-term risk, DMTRF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CYBQY's competition here
DMTRF vs CLVSF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, DMTRF is priced at $2.25, while CLVSF trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CLVSF's P/E ratio is 22.48. In terms of profitability, DMTRF's ROE is +0.36%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, DMTRF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CLVSF's competition here
DMTRF vs CSSPF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CSSPF has a market cap of 273.5M. Regarding current trading prices, DMTRF is priced at $2.25, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CSSPF's P/E ratio is 32.50. In terms of profitability, DMTRF's ROE is +0.36%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CSSPF's competition here
DMTRF vs CYBQF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CYBQF has a market cap of 248.8M. Regarding current trading prices, DMTRF is priced at $2.25, while CYBQF trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CYBQF's P/E ratio is -186.50. In terms of profitability, DMTRF's ROE is +0.36%, compared to CYBQF's ROE of +0.00%. Regarding short-term risk, DMTRF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CYBQF's competition here
DMTRF vs EBRCZ Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, EBRCZ has a market cap of 246.1M. Regarding current trading prices, DMTRF is priced at $2.25, while EBRCZ trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas EBRCZ's P/E ratio is -1.50. In terms of profitability, DMTRF's ROE is +0.36%, compared to EBRCZ's ROE of -1.80%. Regarding short-term risk, DMTRF is more volatile compared to EBRCZ. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check EBRCZ's competition here
DMTRF vs HTLZF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, DMTRF is priced at $2.25, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, DMTRF's ROE is +0.36%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, DMTRF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check HTLZF's competition here
DMTRF vs IMPZY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, DMTRF is priced at $2.25, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, DMTRF's ROE is +0.36%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, DMTRF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check IMPZY's competition here
DMTRF vs XVIPY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, XVIPY has a market cap of 206M. Regarding current trading prices, DMTRF is priced at $2.25, while XVIPY trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas XVIPY's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is +0.36%, compared to XVIPY's ROE of +0.01%. Regarding short-term risk, DMTRF is more volatile compared to XVIPY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check XVIPY's competition here
DMTRF vs VMTHF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, DMTRF is priced at $2.25, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, DMTRF's ROE is +0.36%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, DMTRF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check VMTHF's competition here
DMTRF vs DTXMF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, DMTRF is priced at $2.25, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, DMTRF's ROE is +0.36%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, DMTRF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check DTXMF's competition here
DMTRF vs EKDHF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, EKDHF has a market cap of 167.9M. Regarding current trading prices, DMTRF is priced at $2.25, while EKDHF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas EKDHF's P/E ratio is 39.00. In terms of profitability, DMTRF's ROE is +0.36%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, DMTRF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check EKDHF's competition here
DMTRF vs EAPIF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, EAPIF has a market cap of 162.8M. Regarding current trading prices, DMTRF is priced at $2.25, while EAPIF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas EAPIF's P/E ratio is -0.66. In terms of profitability, DMTRF's ROE is +0.36%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, DMTRF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check EAPIF's competition here
DMTRF vs BRNHF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, BRNHF has a market cap of 161.7M. Regarding current trading prices, DMTRF is priced at $2.25, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, DMTRF's ROE is +0.36%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, DMTRF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check BRNHF's competition here
DMTRF vs JMDMF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, JMDMF has a market cap of 156.4M. Regarding current trading prices, DMTRF is priced at $2.25, while JMDMF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas JMDMF's P/E ratio is 83.33. In terms of profitability, DMTRF's ROE is +0.36%, compared to JMDMF's ROE of N/A. Regarding short-term risk, DMTRF is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check JMDMF's competition here
DMTRF vs BCCOY Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, BCCOY has a market cap of 143M. Regarding current trading prices, DMTRF is priced at $2.25, while BCCOY trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas BCCOY's P/E ratio is -0.90. In terms of profitability, DMTRF's ROE is +0.36%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, DMTRF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check BCCOY's competition here
DMTRF vs CLLKF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CLLKF has a market cap of 136.8M. Regarding current trading prices, DMTRF is priced at $2.25, while CLLKF trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CLLKF's P/E ratio is -0.88. In terms of profitability, DMTRF's ROE is +0.36%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, DMTRF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CLLKF's competition here
DMTRF vs AMEUF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, DMTRF is priced at $2.25, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, DMTRF's ROE is +0.36%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, DMTRF is more volatile compared to AMEUF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AMEUF's competition here
DMTRF vs PXMBF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, PXMBF has a market cap of 119.9M. Regarding current trading prices, DMTRF is priced at $2.25, while PXMBF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, DMTRF's ROE is +0.36%, compared to PXMBF's ROE of -0.03%. Regarding short-term risk, DMTRF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check PXMBF's competition here
DMTRF vs AVHHL Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, AVHHL has a market cap of 105M. Regarding current trading prices, DMTRF is priced at $2.25, while AVHHL trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas AVHHL's P/E ratio is -2.73. In terms of profitability, DMTRF's ROE is +0.36%, compared to AVHHL's ROE of +3.05%. Regarding short-term risk, DMTRF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AVHHL's competition here
DMTRF vs SOMNF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, DMTRF is priced at $2.25, while SOMNF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, DMTRF's ROE is +0.36%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, DMTRF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SOMNF's competition here
DMTRF vs RSHUF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, DMTRF is priced at $2.25, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, DMTRF's ROE is +0.36%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, DMTRF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check RSHUF's competition here
DMTRF vs CKMTF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, DMTRF is priced at $2.25, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, DMTRF's ROE is +0.36%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, DMTRF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CKMTF's competition here
DMTRF vs SNZZF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, SNZZF has a market cap of 78.9M. Regarding current trading prices, DMTRF is priced at $2.25, while SNZZF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas SNZZF's P/E ratio is -5.58. In terms of profitability, DMTRF's ROE is +0.36%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, DMTRF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SNZZF's competition here
DMTRF vs BLOZF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, BLOZF has a market cap of 56.4M. Regarding current trading prices, DMTRF is priced at $2.25, while BLOZF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas BLOZF's P/E ratio is -11.50. In terms of profitability, DMTRF's ROE is +0.36%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, DMTRF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check BLOZF's competition here
DMTRF vs TLTFF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, TLTFF has a market cap of 50.4M. Regarding current trading prices, DMTRF is priced at $2.25, while TLTFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas TLTFF's P/E ratio is -17.05. In terms of profitability, DMTRF's ROE is +0.36%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, DMTRF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check TLTFF's competition here
DMTRF vs NVYTF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, DMTRF is priced at $2.25, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, DMTRF's ROE is +0.36%, compared to NVYTF's ROE of -1.22%. Regarding short-term risk, DMTRF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check NVYTF's competition here
DMTRF vs RDGL Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, RDGL has a market cap of 33.1M. Regarding current trading prices, DMTRF is priced at $2.25, while RDGL trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas RDGL's P/E ratio is -6.71. In terms of profitability, DMTRF's ROE is +0.36%, compared to RDGL's ROE of -1.48%. Regarding short-term risk, DMTRF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check RDGL's competition here
DMTRF vs ACIXF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, ACIXF has a market cap of 31.5M. Regarding current trading prices, DMTRF is priced at $2.25, while ACIXF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas ACIXF's P/E ratio is -2.80. In terms of profitability, DMTRF's ROE is +0.36%, compared to ACIXF's ROE of -1.06%. Regarding short-term risk, DMTRF is more volatile compared to ACIXF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ACIXF's competition here
DMTRF vs POSC Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, POSC has a market cap of 27.4M. Regarding current trading prices, DMTRF is priced at $2.25, while POSC trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas POSC's P/E ratio is -5.82. In terms of profitability, DMTRF's ROE is +0.36%, compared to POSC's ROE of -7.67%. Regarding short-term risk, DMTRF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check POSC's competition here
DMTRF vs MKEAF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, DMTRF is priced at $2.25, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, DMTRF's ROE is +0.36%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, DMTRF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check MKEAF's competition here
DMTRF vs TCLIF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, DMTRF is priced at $2.25, while TCLIF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, DMTRF's ROE is +0.36%, compared to TCLIF's ROE of +2.39%. Regarding short-term risk, DMTRF is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check TCLIF's competition here
DMTRF vs KBBTF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, DMTRF is priced at $2.25, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, DMTRF's ROE is +0.36%, compared to KBBTF's ROE of N/A. Regarding short-term risk, DMTRF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check KBBTF's competition here
DMTRF vs PYNKF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, PYNKF has a market cap of 22.1M. Regarding current trading prices, DMTRF is priced at $2.25, while PYNKF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas PYNKF's P/E ratio is 3.79. In terms of profitability, DMTRF's ROE is +0.36%, compared to PYNKF's ROE of -3.36%. Regarding short-term risk, DMTRF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check PYNKF's competition here
DMTRF vs EMITF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, DMTRF is priced at $2.25, while EMITF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas EMITF's P/E ratio is -7.62. In terms of profitability, DMTRF's ROE is +0.36%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, DMTRF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check EMITF's competition here
DMTRF vs DIZTF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, DMTRF is priced at $2.25, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, DMTRF's ROE is +0.36%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, DMTRF is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check DIZTF's competition here
DMTRF vs VPTDF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, VPTDF has a market cap of 15.9M. Regarding current trading prices, DMTRF is priced at $2.25, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas VPTDF's P/E ratio is -8.47. In terms of profitability, DMTRF's ROE is +0.36%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, DMTRF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check VPTDF's competition here
DMTRF vs GTHP Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, GTHP has a market cap of 15.7M. Regarding current trading prices, DMTRF is priced at $2.25, while GTHP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas GTHP's P/E ratio is -5.11. In terms of profitability, DMTRF's ROE is +0.36%, compared to GTHP's ROE of +0.71%. Regarding short-term risk, DMTRF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check GTHP's competition here
DMTRF vs MDXHF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, DMTRF is priced at $2.25, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, DMTRF's ROE is +0.36%, compared to MDXHF's ROE of +0.66%. Regarding short-term risk, DMTRF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check MDXHF's competition here
DMTRF vs TMDIF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, DMTRF is priced at $2.25, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, DMTRF's ROE is +0.36%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, DMTRF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check TMDIF's competition here
DMTRF vs ASAPF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, ASAPF has a market cap of 13.7M. Regarding current trading prices, DMTRF is priced at $2.25, while ASAPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas ASAPF's P/E ratio is -17.50. In terms of profitability, DMTRF's ROE is +0.36%, compared to ASAPF's ROE of -0.15%. Regarding short-term risk, DMTRF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ASAPF's competition here
DMTRF vs IPDQF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, IPDQF has a market cap of 12.1M. Regarding current trading prices, DMTRF is priced at $2.25, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas IPDQF's P/E ratio is -0.59. In terms of profitability, DMTRF's ROE is +0.36%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, DMTRF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check IPDQF's competition here
DMTRF vs ATBPF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, DMTRF is priced at $2.25, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, DMTRF's ROE is +0.36%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, DMTRF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ATBPF's competition here
DMTRF vs ALRTF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, ALRTF has a market cap of 11.4M. Regarding current trading prices, DMTRF is priced at $2.25, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas ALRTF's P/E ratio is -0.44. In terms of profitability, DMTRF's ROE is +0.36%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, DMTRF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ALRTF's competition here
DMTRF vs LXXGF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, DMTRF is priced at $2.25, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, DMTRF's ROE is +0.36%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, DMTRF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check LXXGF's competition here
DMTRF vs PLLWF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, DMTRF is priced at $2.25, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, DMTRF's ROE is +0.36%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, DMTRF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check PLLWF's competition here
DMTRF vs BIEL Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, BIEL has a market cap of 7.2M. Regarding current trading prices, DMTRF is priced at $2.25, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas BIEL's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is +0.36%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, DMTRF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check BIEL's competition here
DMTRF vs QLIS Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, DMTRF is priced at $2.25, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas QLIS's P/E ratio is 2.22. In terms of profitability, DMTRF's ROE is +0.36%, compared to QLIS's ROE of -0.15%. Regarding short-term risk, DMTRF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check QLIS's competition here
DMTRF vs RHNMF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, DMTRF is priced at $2.25, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, DMTRF's ROE is +0.36%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, DMTRF is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check RHNMF's competition here
DMTRF vs PMEDF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, PMEDF has a market cap of 5.2M. Regarding current trading prices, DMTRF is priced at $2.25, while PMEDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas PMEDF's P/E ratio is -2.52. In terms of profitability, DMTRF's ROE is +0.36%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, DMTRF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check PMEDF's competition here
DMTRF vs ADMT Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, ADMT has a market cap of 4.7M. Regarding current trading prices, DMTRF is priced at $2.25, while ADMT trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas ADMT's P/E ratio is -6.90. In terms of profitability, DMTRF's ROE is +0.36%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, DMTRF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ADMT's competition here
DMTRF vs USAQ Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, USAQ has a market cap of 4.1M. Regarding current trading prices, DMTRF is priced at $2.25, while USAQ trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas USAQ's P/E ratio is 11.17. In terms of profitability, DMTRF's ROE is +0.36%, compared to USAQ's ROE of +0.92%. Regarding short-term risk, DMTRF is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check USAQ's competition here
DMTRF vs RMSL Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, RMSL has a market cap of 3.7M. Regarding current trading prices, DMTRF is priced at $2.25, while RMSL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas RMSL's P/E ratio is 0.22. In terms of profitability, DMTRF's ROE is +0.36%, compared to RMSL's ROE of -17961324.55%. Regarding short-term risk, DMTRF is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check RMSL's competition here
DMTRF vs VANIW Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, DMTRF is priced at $2.25, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas VANIW's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is +0.36%, compared to VANIW's ROE of -2.64%. Regarding short-term risk, DMTRF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check VANIW's competition here
DMTRF vs NGMDF Comparison June 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 270.5M. In comparison, NGMDF has a market cap of 3.3M. Regarding current trading prices, DMTRF is priced at $2.25, while NGMDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -112.50, whereas NGMDF's P/E ratio is -0.49. In terms of profitability, DMTRF's ROE is +0.36%, compared to NGMDF's ROE of +0.94%. Regarding short-term risk, DMTRF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check NGMDF's competition here